NCT03236506View on ClinicalTrials.gov

A Direct obserVed therApy vs fortNightly CollEction Study for HCV Treatment - ADVANCE HCV Study

PHASE2CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

January 19, 2018

Primary Completion Date

August 31, 2020

Study Completion Date

October 28, 2020

Conditions
Hepatitis C
Interventions
DRUG

Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet

Drugs will be given to participants to treat hepatitis C infection

BEHAVIORAL

Psychological intervention

"Participants randomised to fortnightly pick-up with psychological intervention will have an interview with the study nurse designed to aid their compliance with the drug regimen. During the intervention participants will be guided by their trial nurse in the completion of a personalised booklet, Hepatitis C and Me. The booklet uses the principles of node-link mapping to structure the intervention."

DRUG

Sofosbuvir 400 MG

Drugs will be given along with Zepatier to participants to treat genotype 3hepatitis C infection

Trial Locations (2)

DD1 9SY

University of Dundee, Dundee

NHS Tayside, Dundee

All Listed Sponsors
lead

University of Dundee

OTHER

NCT03236506 - A Direct obserVed therApy vs fortNightly CollEction Study for HCV Treatment - ADVANCE HCV Study | Biotech Hunter | Biotech Hunter